Dr. Eric Lancaster, MD

Dr. Lancaster practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Lancaster's NPI, 1851456016, was assigned on December 27, 2006. Dr. Lancaster graduated from University of Maryland School of Medicine in 2003. Dr. Lancaster holds Pennsylvania license MD431643.

Dr. Lancaster's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Lancaster's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Lancaster is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Lancaster to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lancaster practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lancaster's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lancaster is licensed in Pennsylvania.

CMS data shows 634 Medicare services from Dr. Lancaster across 9 procedure codes in 2024, for 245 Medicare patients. Medicare paid $34,029 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 245 Medicare patients who saw Dr. Lancaster in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lancaster's median patient age at 61, with 53% women.

In 2024, Dr. Lancaster wrote 581 Medicare Part D claims for 68 patients. 70% of them were for generic drugs. CMS names the drug for 487 of them, across 17 drugs with 11 or more claims each, at $2,075,069 in total drug cost. In 2023, CMS named 317 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Lancaster for performance year 2024, reported as part of a group. Dr. Lancaster accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lancaster as offering telehealth.

Dmand AI links 48 papers to Dr. Lancaster, published from 2009 to 2024. 2018 was the busiest year, with 6. The most frequent topics are Autoantibodies, Nerve Tissue Proteins and Encephalitis. Dr. Lancaster has published most often in Neurol Neuroimmunol Neuroinflamm. Dr. Lancaster's most frequent co-authors are Steven S. Scherer, MD, Carl June, MD and Myrna R. Rosenfeld, MD.

CMS Open Payments shows 33 general payments to Dr. Lancaster from 6 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 47% of the total. Grifols Shared Services North America, Inc. paid the most, $11,436.

Dr. Lancaster graduated from University of Maryland School of Medicine in 2003.